Prognostic factors and significance of the revised 6th edition of the AJCC classification in patients with locally advanced nasopharyngeal carcinoma
- PMID: 16896592
- DOI: 10.1007/s00066-006-1538-4
Prognostic factors and significance of the revised 6th edition of the AJCC classification in patients with locally advanced nasopharyngeal carcinoma
Abstract
Purpose: To compare the 4th edition 1992 and 6th edition 2002 of the American Joint Committee on Cancer (AJCC) staging systems, to evaluate the paranasopharyngeal structures and lymph node involvement, and to define the prognostic significance of the above factors to overall survival (OS) in patients with locally advanced nasopharyngeal carcinoma (NPC).
Patients and methods: CT images of 162 patients, who were diagnosed with NPC and received irradiation alone or chemotherapy and irradiation, were retrospectively reviewed. CT scans, performed prior to and after the completion of treatment, were reviewed.
Results: The parapharyngeal space was found to be involved very commonly (98%). 50 of 162 patients (31%) displayed parapharyngeal extension of the tumor to degree A, 59 patients (36%) showed degree B, and 50 patients (31%) degree C nasopharyngeal extension. According to the AJCC 6th edition 2002, patients were distributed into stages IIA, IIB, III, IVA, and IVB. By contrast, using the AJCC 4th edition 1992, patients were distributed into stages III and IV only. After a median follow up of 71.1 months, median survival was 60.7 months, with a 2-year survival rate of 71.3% and a 3-year survival rate of 62.2%. Multivariate analysis identified age, degree of parapharyngeal lateral extension, cavernous-sinus-infiltration, and size of infiltrated lymph nodes as independent prognostic factors for OS.
Conclusion: The 6th revision of TNM staging reported herein, provides a more uniform distribution of patients between stages. The degree of tumor extension into the parapharyngeal space should be considered in future TNM staging revisions.
Similar articles
-
Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma. A significant factor in local control and distant metastasis.Cancer. 1996 Jul 15;78(2):202-10. doi: 10.1002/(SICI)1097-0142(19960715)78:2<202::AID-CNCR3>3.0.CO;2-N. Cancer. 1996. PMID: 8673993
-
Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.Radiother Oncol. 2004 Jul;72(1):71-7. doi: 10.1016/j.radonc.2004.02.012. Radiother Oncol. 2004. PMID: 15236877
-
Another way to estimate outcome of advanced nasopharyngeal carcinoma--is concurrent chemoradiotherapy adequate?Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):156-64. doi: 10.1016/j.ijrobp.2004.03.002. Int J Radiat Oncol Biol Phys. 2004. PMID: 15337551 Clinical Trial.
-
Classification of lymph node metastases from gastric cancer: comparison between N-site and N-number systems. Our experience and review of the literature.Am Surg. 2007 Apr;73(4):359-66. Am Surg. 2007. PMID: 17439029 Review.
-
[Radiotherapy of carcinoma of the nasopharynx. Results and analysis of prognostic factors].Radiol Med. 1990 Oct;80(4):501-5. Radiol Med. 1990. PMID: 2244039 Review. Italian.
Cited by
-
A comparison between the sixth and seventh editions of the UICC/AJCC staging system for nasopharyngeal carcinoma in a Chinese cohort.PLoS One. 2014 Dec 23;9(12):e116261. doi: 10.1371/journal.pone.0116261. eCollection 2014. PLoS One. 2014. PMID: 25536307 Free PMC article.
-
Long-Term Results of Concurrent Chemoradiotherapy for Advanced N2-3 Stage Nasopharyngeal Carcinoma.PLoS One. 2015 Sep 14;10(9):e0137383. doi: 10.1371/journal.pone.0137383. eCollection 2015. PLoS One. 2015. PMID: 26367317 Free PMC article.
-
Simultaneous integrated boost intensity-modulated radiotherapy (SIB‑IMRT) in nasopharyngeal cancer.Strahlenther Onkol. 2010 Mar;186(3):135-42. doi: 10.1007/s00066-010-2048-y. Epub 2010 Feb 22. Strahlenther Onkol. 2010. PMID: 20339827
-
Correlation of the AKT/mTOR signaling pathway with the clinicopathological features and prognosis of nasopharyngeal carcinoma.Eur J Histochem. 2021 Nov 16;65(4):3304. doi: 10.4081/ejh.2021.3304. Eur J Histochem. 2021. PMID: 34783234 Free PMC article. Clinical Trial.
-
LOX expression in primary nasopharyngeal carcinoma: correlation with prognostic parameters and outcome.Oncotarget. 2016 Feb 16;7(7):8200-7. doi: 10.18632/oncotarget.6996. Oncotarget. 2016. PMID: 26882568 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical